The prognosis for pelvic cancer, depending on its stage at diagnosis, has a five-year survival rate between 93 and 15 percent, according to Cancer.org. These percentages come from patients who have undergone treatment for five years, meaning that technological improvements in treatment methods may improve actual results, and they include deaths not caused by cancer.
The five-year survival rate for patients diagnosed with stage 0 pelvic cancer is 93 percent, according to data collected by Cancer.org on patients diagnosed between the years 2000 and 2002. The rate stays the same for patients with stage IA pelvic cancer and drops to 80 percent for patients with stage IB. Patients with stage IIA pelvic cancer have a five-year survival rate of 63 percent, while patients with stage IIB have a rate of 58 percent. Patients with stage IIIA have a 35 percent five-year survival rate, which drops down to 32 percent for stage IIIB cancer. The rate is 16 percent for stage IVA and 15 percent for stage IVB.
These prognoses are general, do not take into account how well the cancer responds to treatment or the patient's general health, and cannot predict what may happen to any particular person, according to Cancer.org.
